284 related articles for article (PubMed ID: 24450344)
1. Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy.
Nagasaki T; Akiyoshi T; Ueno M; Fukunaga Y; Nagayama S; Fujimoto Y; Konishi T; Yamaguchi T
Asian J Endosc Surg; 2014 Jan; 7(1):52-5. PubMed ID: 24450344
[TBL] [Abstract][Full Text] [Related]
2. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
[TBL] [Abstract][Full Text] [Related]
3. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
Hirano A; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Imai K; Nakagawa R; Adachi K; Shiragami R; Yasuda H
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1087-91. PubMed ID: 22790044
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
Konishi T; Shinozaki E; Murofushi K; Taguchi S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Suenaga M; Chino A; Kawachi H; Yamamoto N; Ishikawa Y; Oguchi M; Ishizuka N; Ueno M; Yamaguchi K
Ann Surg Oncol; 2019 Aug; 26(8):2507-2513. PubMed ID: 30963400
[TBL] [Abstract][Full Text] [Related]
7. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
[TBL] [Abstract][Full Text] [Related]
8. Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.
Selvindos PB; Ho YH
Dis Colon Rectum; 2008 Nov; 51(11):1710-1. PubMed ID: 18679748
[TBL] [Abstract][Full Text] [Related]
9. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
[TBL] [Abstract][Full Text] [Related]
10. Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX.
Liang JT; Lai HS; Cheng KW
Surg Endosc; 2011 Jan; 25(1):305-8. PubMed ID: 20526625
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of advanced rectal cancer resected successfully after neoadjuvant chemotherapy with FOLFOX regimen].
Shimizu H; Taniguchi F; Sonoda H; Itokawa Y; Ikeda J; Yamashita T; Koide K; Ueshima Y; Takashina K; Lee CJ; Shioaki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2073-5. PubMed ID: 20037327
[TBL] [Abstract][Full Text] [Related]
12. Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.
Bensignor T; Brouquet A; Dariane C; Thirot-Bidault A; Lazure T; Julié C; Nordlinger B; Penna C; Benoist S
Colorectal Dis; 2015 Jun; 17(6):491-8. PubMed ID: 25524450
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
14. [A case of locally advanced rectal cancer successfully treated by laparoscopic intersphincteric resection and effective neoadjuvant chemoradiation therapy].
Kanamoto A; Nakano T; Ojima E; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1974-7. PubMed ID: 24393984
[TBL] [Abstract][Full Text] [Related]
15. [A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection].
Kimura K; Kagawa Y; Kato T; Ishida T; Morimoto Y; Matusita K; Kusama H; Hashimoto T; Katura Y; Nitta K; Takeno A; Nakahira S; Okishiro M; Sakisaka H; Taniguchi H; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1740-2. PubMed ID: 25731314
[TBL] [Abstract][Full Text] [Related]
16. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
17. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
[TBL] [Abstract][Full Text] [Related]
18. [Complete clinical and pathological response to mFOLFOX6 neoadjuvant chemotherapy in a case of advanced rectal cancer].
Mori K; Kikunaga H; Morisue A; Fujita K; Ishikawa K; Sakuragawa T; Kumai K; Miura H; Mikami S
Gan To Kagaku Ryoho; 2012 Apr; 39(4):679-82. PubMed ID: 22504702
[TBL] [Abstract][Full Text] [Related]
19. Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: report of a case.
Itatani Y; Akiyoshi T; Kuroyanagi H; Yamakawa K; Noaki R; Konishi T; Fujimoto Y; Ueno M; Oya M; Suenaga M; Yamaguchi T
Surg Today; 2012 Jan; 42(1):75-9. PubMed ID: 22075663
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
